Volume: 20 Issue: 1

The New Journal of Urology (New J Urol) is a scientific, peer-reviewed, open access publication and it aims to improve the standards in the field of urology including the education of academicians and the professionals.The New Journal of Urology (New J Urol) is a scientific, referred, open access publication of the Eurasian Urooncological Association. The society is a non-profit organization and it aims to increase the standards in the field of urology including education of the academicians, professionals and public. The society The New Journal of Urology also aims to create or make contributions for the development of technical, scientific and social facilities and it also cooperates with any and all related institutions, organizations, foundations and societies from the national and international area for this purpose.

The journal' s financial expenses are covered by the Eurasian Urooncological Association. The journal is published quarterly tri-annual– (three times a year)- in February, June and October, respectively and the language of the journal is Turkish and English.

The purpose of the New Journal of Urology The New Journal of Urology is to contribute to the literature by publishing urological manuscripts such as scientific articles, reviews, letters to the editor, case reports, reports of surgical techniques, surgical history, ethics, surgical education and articles of forensic medicine.

The target audience of the journal is urologists, specialist doctors and other professionals interested in the field of urology.

The New Journal of Urology has been indexed by TUBITAK ULAKBIM-TR DİZİN, Google Schoolar, Scilit, EBSCO, DOAJ, SOBIAD Citation Index, J-GATE, İdeal Online, Turkish Citation Index, and TurkMedline (National Health Sciences-Periodicals Database).

Yeni Üroloji Dergisi/The New Journal of Urology ceased printing in 2024 (ISSN: 1305-2489, eISSN: 2687-1955).

The New Journal of Urology is now only published online with the eISSN: 3023-6940.

The journal is integrated with ORCID and CrosReff DOI.

All published content is available for free at https://newjournalurology.com/archive.

All manuscripts submitted to the journal should be submitted via the online submission system, which is available at the https://dergipark.org.tr/en/journal/4362/submission/step/manuscript/new.

Instructions for authors, including technical information and required forms, can be found at https://dergipark.org.tr/en/pub/newurology/writing-rules.

Editorial and publication processes of the journal are shaped in accordance with the guidelines of the international organizations such as the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE). Our journal follows the principles of transparency and best practices for scholarly publishing as identified by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME)

COPE DOAJ OASPA WAME. Principles of Transparency and Best Practice in Scholarly Publishing — English.
https://doi.org/10.24318/cope.2019.1.12.

The statements and/or opinions indicated at the articles which are published at the journal reflect the views of the author, not the opinions of the editors, editorial board and / or the Publisher. Editors and publishers do not accept any responsibility for such materials.

No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Authors' credentials and e-mail addresses are in no way used for other purposes.

The journal will allow the authors to retain publishing rights without restrictions.

All published content in The New Journal of Urology are licensed under Creative Commons CC BY Attribution 4.0 International License. Authors consent to publication of their work by The New Journal of Urology under a Creative Commons CC BY Attribution 4.0 International License.

Editor-in-Chief

Ali İhsan Taşçı

Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye

E-mail: aliihsantasci@hotmail.com

ORCID ID: https://orcid.org/0000-0002-6943-6676

Editor

Yavuz Onur Danacıoğlu

Department of Urology, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye

E-mail: dr_yonur@hotmail.com

ORCID ID: https://orcid.org/0000-0002-3170-062X

Deputy Editor-in-Chief

Mithat Ekşi

Department of Urology, Dr.Sadi Konuk Training and Research Hospital, Istanbul, Türkiye

E-mail: mithat_eksi@hotmail.com

ORCID ID: https://orcid.org/0000-0003-1490-3756

Publishing Services

Pera Publishing Services

Address: Ataköy 3-4-11 Kısım Mah. Dr Remzi Kazancıgil Cd. O-114 N:12 D:7 PC: 34158, Bakırköy, İstanbul / Türkiye

E-mail: info@perayayincilik.com

Writing Rules

General Guidelines

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/journal/4362/submission/step/manuscript/new. Manuscripts submitted via any other medium will not be evaluated. Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. The editor reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. Editors have the right to make corrections without changing the main text. The ORCID (Open Researcher and Contributor ID) number of the authors should be provided while sending the manuscript. A free registration can be done at https://orcid.org.

For experimental, clinical, and drug studies mandated to be approved by an ethical committee for publication in The New Journal of Urology, the authors must furnish an ethical committee approval report in line with international agreements (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/).

In the case of experimental animal studies, adherence to animal rights guidelines ("Guide for the Care and Use of Laboratory Animals" https://www.ncbi.nlm.nih.gov/books/NBK54050) is mandatory, with requisite approval from the animal ethics committee.

The "Materials and Methods" section must specify the ethical committee's approval, including the approval number, and the provision of "informed consent" by patients.

Authors are obligated to disclose conflicts of interest and financial support related to their articles.

The rules for the title page, references, figures and tables are valid for all types of articles published in this journal.

Authors are required to submit the following:

• Cover Letter

• Copyrıght Agreement and Acknowledgement of Authorship Form

• Patient Consent Form

• ICMJE Disclosure of Interest

• Title Page (Please visit the following link for a sample design)

• Main text

• Figures

• Tables

PREPARATION OF THE MANUSCRIPT

Authors should adhere to the ICJME recommendations for “preparing a manuscript for submission to a medical journal”. https://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html

The articles should be written in 12-point, Times New Roman, double-spaced with at least 2.5 cm margin on all edges of each page. The main text should not include any information about the authors' names or affiliations. This information should only be included on the title page, along with their ORCID IDs, the title, abstract, and keywords.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be explained clearly in parentheses following the definition and custom abbreviations should not be used.

Statistical analysis is usually necessary to support results in original articles. Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.

Whenever a product, software, or software program is mentioned in the main text, product information (including state in the USA) must be given in parentheses, including the product name, product manufacturer, city of production, and country of the company.

All references, tables, and figures should be sequentially numbered and referred to in the main text. All pages of the manuscript should be numbered at the bottom center, except for the title page. Papers should include the necessary number of tables and figures to provide better understanding.

Authors are required to prepare manuscripts in accordance with the relevant guideline listed below:

• Randomized research studies and clinical trials: CONSORT guidelines (for protocols, please see the SPIRIT guidance)

• Observational original research studies: STROBE guidelines

• Studies on diagnostic accuracy: STARD guidelines

• Systematic reviews and meta-analysis: PRISMA guidelines (for protocols, please see the PRISMA-P guidelines)

• Experimental animal studies: ARRIVE guidelines and Guide for the Care and Use of Laboratory Animals, 8th edition

• Nonrandomized evaluations of behavioral and public health interventions: TREND guidelines

• Case report: the CARE case report guidelines

• Genetic association studies: STREGA

• Qualitative research: SRQR guidelines

Manuscript Types

Original Articles

For original research, systematic reviews, and meta-analyses, structured abstracts are required. The abstract should provide background information and state the study's purpose, procedures (including participant selection, settings, measurements, and analytical methods), main findings (including specific effect sizes and their statistical and clinical significance, if possible), and principal conclusions. Abstracts should highlight novel and significant findings, acknowledge important limitations, and avoid overinterpretation. Inclusion of the essential elements identified by the CONSORT group is essential for clinical trial abstracts.

Original Research Articles should include subheadings below;

• Title

• Abstract

• Keywords

• Introduction

• Material and Methods

• Results

• Discussion

• Conclusions

• Figures and Tables Legend

• References

Review Articles

Review articles should provide a comprehensive overview of the current state of knowledge on a topic in clinical practice, and should include discussions and evaluations of relevant research. The subheadings of the review articles can be planned by the authors. Review articles are scientific analyses of recent developments on a specific topic as reported in the literature. No new information is described, and no opinions or personal experiences are expressed.

• Title

• Abstract (unstructured)

• Keywords

• Main text

• Conclusion

• Figures and Tables Legend

• References

Case Reports

New, interesting and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority.

Case Reports should include subheadings below;

• Title

• Abstract (unstructured)

• Keywords

• Introduction

• Case Presentation

• Discussion and Conclusion

• Figures and Tables Legend

• References

Letters to the Editor

A "Letter to the Editor" is a type of manuscript that discusses important or overlooked aspects of a previously published article. This type of manuscript may also present articles on subjects within the scope of the journal that are of interest to readers, particularly educational cases. Readers can also use the "Letter to the Editor" format to share their comments on published manuscripts. The text of a "Letter to the Editor" should be unstructured and should not include an abstract, keywords, tables, figures, images, or other media.

Letters to Editor should include subheadings below;

• Title

• Keywords

• Main text

• Figures and Table Legend

• References

Article Structure

Title page

A separate title page should be submitted with all submissions.

The title page should include:

1- The full title of the manuscript as well as a short title (running head) of ≤50 characters,

2- Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s),

3- Name, address, telephone (including the mobile phone number), and email address of the corresponding author,

4- If the author(s) is a member of the journal’s Editorial Board, this should be specified in the title page,

5- If the content of the paper has been presented before, and if the summary has been published, the time and place of the conference should be denoted on this page,

6- If any grants or other financial support has been given by any institutions or firms for the study, information must be provided by the authors,

7- Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria should be included.

Abstract

Original articles should have a structured English (Objective, Methods, Results, Conclusion). Review articles and case reports should have an unstructured abstract. Articles and abstracts should be written in accordance with the word limits specified in the table. References, tables and citations should not be used in an abstract.

Keywords

Each submission must be accompanied by a minimum of three to a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).

Limitations for each manuscript type;

Type of Article	Abstract word limit	Word limit	References limit	Table limit	Figure limit
Original Article	250 (Structured)	3000	30	6	5
Review Article	250 (Unstructured)	4000	50	6	6
Case Reports	250 (Unstructured)	2000	10	1	3
Letter to the Editor	No abstract	1000	5	1	1

Figures and Tables

Figures, graphics, illustrations and photographs should be submitted as separate files (in JPEG or PNG format) through the submission system. The files should not be embedded in a word file of the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system.

Figures should be labeled with Arabic numbers. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks may be used on the images to support figure legends. The minimum resolution of each submitted figure should be 300 DPI. Written informed consent for publication must be obtained for all images and must not allow patients to be identified. Figure legends should be listed at the end of the main document. Figures must be numbered consecutively in the order in which they are mentioned in the main text.

Tables should not embed in the main document. Tables should support and enhance the main text rather than repeat data presented in the main text. All tables should be numbered consecutively in the order they are used to within the main text. Table legends should be listed at the end of the main document.

Units of Measurement

Units of length, weight and volume should be reported in metric (meter, kilogram, liter) system and in decimal multiples. Temperatures should be expressed in degrees Celsius, and blood pressures in millimeters of mercury. Both local and International Unit Systems (International System of Units, SI) should be used as measurement units. Drug concentrations should alternatively be given in either SI units or mass units written in parentheses.

Abbreviations and Symbols

Use only standard abbreviations, non-standard abbreviations can be very confusing for the reader. The use of abbreviation(s) should be avoided in the title. If there is no standard unit of measurement, provide the long version of the abbreviation in parentheses when it is first used in the text.

Supplementary Materials

Supplementary materials, including audio files, videos, datasets, and additional documents (e.g., appendices, additional figures, tables), are intended to complement the main text of the manuscript. These supplementary materials should be submitted as a separate section after the references list. Concise descriptions of each supplementary material should be included to explain their relevance to the manuscript. Page numbers are not required for supplementary materials.

Identifying Products

When mentioning a drug, product, hardware, or software program in a manuscript, it is important to provide detailed information about the product in parentheses. This should include the name of the product, the producer of the product, and the city and country of the company.

Author Contributions

When submitting to The New Journal of Urology, corresponding authors must provide a signed and scanned authorship contribution form, which can be downloaded from https://dergipark.org.tr/en/pub/newurology/page/16601. This requirement is in place to ensure proper authorship attribution and prevent ghost or honorary authorship.

References

While citing publications, preference should be given to the latest, most up-to-date publications. Authors should avoid using references that are older than ten years. All the references should be written according to the Vancouver reference style. The references used in the article must be written in parenthesis, at the end of the sentences. References should be numbered in the order they appear in the text and listed in the same order in which they are cited in the text. Be consistent with your referencing style across the document.

References must contain surnames and initials of all authors, article title, name of the journal, the year and the first and last page numbers. If there are more than 6 authors, an abbreviation of “et al.” should be used for the authors out of the first three.

You must add the DOI (Digital object identifier) at end of each reference.

For Examples

Article in journal:

Tasci A, Tugcu V, Ozbay B, et al. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol.2009;23:1879-1881. https://doi.org/10.1089/end.2008.0596

For Books:

Günalp İ. Modern Üroloji. Ankara: Yargıçoğlu Matbaası, 1975.

Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders, 2003; p. 288-307.

For website;

Gaudin S. How moon landing changed technology history [serial online]. 2009 [cited 2014 June 15]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/

For conference proceeding;

Anderson JC. Current status of chorion villus biopsy. Paper presented at: APSB 1986. Proceedings of the 4th Congress of the Australian Perinatal Society, Mothers and Babies; 1986 Sep 8-10; Queensland, Australian. Berlin: Springer; 1986. p. 182-191.

For Thesis;

Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Süleyman Demirel Üniversitesi Tıp Fakültesi Spor Hekimliği Anabilim Dalı Uzmanlık Tezi. Isparta: Süleyman Demirel Üniversitesi; 2016.

Manuscript Retraction

For any other reason authors may withdraw their manuscript from the journal with a written declaration.

Revisions

When submitting a revised version of a paper, the author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial period is over.

After Acceptance

Accepted manuscripts are copy-edited for grammar, punctuation, and format. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested. The journal owner and the editorial board are authorized to decide in which volume of the accepted article will be printed. Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.

Requests for author change (name, author addition) will be evaluated if submitted to the Editorial Board (publisher/journal address) with a letter signed by all authors before the evaluation process is completed. No author changes will be made after the article is assigned to the issue and published.

Ethical Principles and Publication Policy

Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/).

The ethics of The New Journal of Urology have been established in accordance with the guidelines of Committee on Publication Ethics (COPE) (https://doi.org/10.24318/cope.2019.2.24).

The Editorial Board follows to the recommendations of International Committee of Medical Journal Editors (ICJME) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.

An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) is required for experimental, clinical, and drug studies and for some case reports.

If required, ethics committee reports or an equivalent official document will be requested from the authors.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.. https://doi.org/10.24318/cope.2019.2.26

Disclosure of Conflicts of Interest

A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the Acknowledgments section within the manuscript.

The “Copyright Agreement and Acknowledgement of Authorship Form” should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript.

The Editorial Board of The New Journal of Urology will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check (iThenticate). When malpractices are found in the submitted article to The New Journal of Urology, Editorial Board will follow the flowchart by the Committee on Publication Ethics (COPE) for settlement of any misconduct. The Editorial Board of The New Journal of Urology is always willing to publish corrections, clarifications, retractions when needed.

Responsibilities of Author

The New Journal of Urolgy requires each submission to be accompanied by Copyright Agreement and Acknowledgement of Authorship Form. When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.

• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.

• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.

• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.

All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 20%.

Statements or opinions expressed in the manuscripts published in The New Journal of Urology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility in regard to the published content rests with the authors.

The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics guidelines (COPE). In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor-in-Chief is the final authority in the decision-making process for all appeals and complaints.

Open Access&Deposit Policy

Open Access Policy

The New Journal of Urology is committed to the principles of open access, ensuring that all research published in the journal is freely accessible to readers without subscription fees or other access barriers.
Every paper published in The New Journal of Urology is freely available via the website https://dergipark.org.tr/en/pub/newurology/archive.
All articles in The New Journal of Urology are published under the Creative Commons CC BY Attribution 4.0 International license. This licensing model allows users to copy, distribute, remix, transform, and build upon the material, including for commercial purposes, provided that appropriate credit is given to the original authors and source.
Authors retain full copyright over their work.
To promote immediate and unrestricted access, all articles are made available on the journal’s website without any embargo periods. The New Journal of Urology encourages authors to self-archive their published work in institutional repositories, personal websites, or other platforms, further enhancing the accessibility and dissemination of their research.
This open-access policy aligns with our mission to advance knowledge in urology and support the global scientific community by making high-quality research widely accessible.

The New Journal of Urology follows the principles of transparency and best practices for scholarly publishing as identified by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME).

COPE DOAJ OASPA WAME. Principles of Transparency and Best Practice in Scholarly Publishing — English.
https://doi.org/10.24318/cope.2019.1.12
2022 COPE, DOAJ, OASPA, WAME

Archiving and Distribution Policy

Archiving
To secure the durability and availability of the published material (publisher's version/PDF), articles are systematically archived in multiple reliable repositories, including:
Publisher’s Archive: All articles are stored in the official archives of The New Journal of Urology for long-term access.
Crossref: Articles are registered with unique Digital Object Identifiers (DOIs), ensuring their discoverability and permanence in digital environments.
Institutional Repositories: Authors are encouraged to deposit the final published version of their articles in their affiliated institutional repositories.
Author’s Personal Websites: Authors may archive their work on personal or professional websites, enhancing the visibility of their research.

Distribution
Authors are free to share and distribute their articles, provided the original source is properly acknowledged. Key guidelines for distribution include:
Citation Standards: When sharing or redistributing their work, authors and readers must provide accurate citations, including the DOI link to the publisher’s version. This practice ensures proper credit and academic integrity.
Self-Archiving: Authors are encouraged to self-archive their articles on platforms such as institutional repositories, social media, or academic networking sites, provided the publisher’s final version is used for reference.
Open Access Availability: All articles are published under the Creative Commons CC BY Attribution 4.0 International License, allowing unrestricted sharing, adaptation, and reuse, provided appropriate credit is given to the original authors and source.

By adopting these practices, The New Journal of Urology ensures that your research remains widely accessible, discoverable, and preserved for future generations of scholars and practitioners.

Copright&Licensing

The New Journal of Urolgy requires each submission to be accompanied by a Copyrıght Agreement and Acknowledgement of Authorship Form.

All of the authors have to confirm the originality of the study and their own contribution to the study.

When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

The contents can be used as a reference in scientific publications and presentations.

The New Journal of Urology allows the author to retain copyright without restriction.

There is no charge for publishing, or no copyright fee is paid to the authors.

No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Lisencing

All published content in The New Journal of Urology are licensed under Creative Commons Attribution CC-BY 4.0 International License. Authors consent to publication of their work by The New Journal of Urology under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Under this licence, the third parties and authors are free to copy, distribute, transmit, adapt, and even make commercial use of the material, provided the article is properly cited.

Provided that the original author(s) and citation details are acknowledged, the authors grant any third party the right to use the article freely.
Authors grant this journal permission to publish the article and to identify itself as the original publisher.

The manuscript should be cited using the DOI, as provided by the journal.
The authors have confirmed their contribution to this work and have read and signed the conflict of interest declaration. Authors warrant that they have approved and are responsible for the article or any material contained therein.
The authors must ensure that the study under consideration is original and does not contain plagiarized content. The content in question must be original and not otherwise under copyright elsewhere (in whole or in part).
The authors warrant that the contribution or any material contained therein has not been published previously and will not be submitted for publication elsewhere.
The authors must avoid duplicate publication, which is reproducing verbatim content from their other publications.
The authors retain copyright without restriction.
All commercial rights associated with the contribution are retained by the contributors.
Nothing in this licence should be construed as impinging on the author's right to maintain the integrity and ownership of his or her work or as detracting from or restricting it.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.

https://doi.org/10.24318/cope.2019.2.26

Plagiarism

Authors are required to confirm that their submitted work is original and has not been published or submitted elsewhere in any form. All manuscripts undergo a rigorous plagiarism check using iThenticate, a widely recognized tool for detecting text similarities in academic publications (excluding abstracts and reference sections). Submissions with a similarity rate exceeding 20% may be rejected or returned for revision at the discretion of the editorial board.
In cases of significant overlap with previously published material, the editorial team follows the guidelines of the Committee on Publication Ethics (COPE) to evaluate and address potential breaches of ethical standards. While limited text recycling may be permissible in specific manuscript sections—such as methods or introductions—authors must avoid unnecessary duplication and explicitly cite any reused material.
The duplication of results, figures, or tables without proper attribution or justification is strictly prohibited. Any reuse of content must be transparent, appropriately attributed, and in compliance with copyright regulations.
If suspected plagiarism is found in an article either before (by reviewers or editorial team) or after (by readers) publication, the journal will act according to COPE’s code of conduct and flowcharts.
COPE guidelines: COPE Council. All flowcharts. https://doi.org/10.24318/cope.2019.2.26

Retraction Policy

A published article may be retracted if it is determined that:
•   The data or findings are significantly unreliable due to errors, miscalculations, or experimental flaws.
•   Ethical violations have occurred, such as data fabrication, falsification, or plagiarism.
•   There is evidence of undeclared conflicts of interest or unauthorized use of copyrighted material.
•   The research breaches ethical standards involving human or animal subjects.

Retractions are issued to alert readers to major issues while preserving the integrity of the scientific record. Retraction notices will clearly state:
•   The title and authors of the retracted article.
•   The reason(s) for the retraction, including any supporting evidence.
•   A statement clarifying whether the error was unintentional or due to misconduct.

Retraction notices will remain permanently linked to the original article's DOI and will be freely accessible to readers. The original article will not be removed but will be clearly marked as retracted.

Correction Policy

In cases where the article’s findings remain reliable, but minor errors or inaccuracies are identified, a correction will be issued instead of a retraction. Examples include:
•   Typographical errors or formatting mistakes that do not affect the interpretation of data.
•   Errors in author affiliations or funding acknowledgments.
•   Inaccuracies in references or minor methodological descriptions.

Corrections will follow a thorough review by the editorial team to ensure they address the issue without compromising the article's validity. A correction notice will include:
•   A clear description of the error.
•   The corrected content.
•   A reference to the original article’s DOI.

Procedure for Retraction or Correction

The retraction or correction process may be initiated by authors, readers, or the editorial team. Requests must be submitted to the editorial office with supporting evidence of the issue. Each case will be carefully reviewed by the editor-in-chief and, where necessary, external experts to ensure an impartial decision.
It is imperative to emphasise that, in all circumstances, the Editor is obligated to adhere to the guidelines stipulated by the Committee on Publication Ethics (COPE) with regard to retraction and correction. This commitment ensures that any decision pertaining to such matters is made with utmost transparency and in strict accordance with the most efficacious practices.

COPE Council. COPE Guidelines: Retraction Guidelines. November 2019.
https://doi.org/10.24318/cope.2019.1.4

Declaration of Generative AI in Scientific Writing

Nowadays, the use of artificial intelligence in the writing of original research articles is becoming widespread thanks to the developing technological conditions. The author is obliged to follow the ethical standards regarding the use of artificial intelligence in the writing of articles submitted to the New Journal of Urology. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. This may constitute standard plagiarism as the use of AI does not meet the criteria for authorship.

Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. The editors and reviewers of the New Journal of Urology are careful to evaluate the text in terms of the use of artificial intelligence tools that can generate references.

Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process. A statement should appear in the published work. Please note that authors are ultimately responsible and accountable for the contents of the work.

Price Policy

There is no charge for publishing, or no copyright fee is paid to the authors.
No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Download Cover Image

Issue Files

Archive

Volume: 20 Issue: 1, 2/27/25

Research Article

Page : 1-12

Page : 13-20

Page : 21-31

Page : 32-39

Page : 40-46

Case Reports

Page : 47-50

Reviews

Page : 51-63

Issue Editorial Board

Aim & Scope

Writing Rules

General Guidelines

PREPARATION OF THE MANUSCRIPT

Ethical Principles and Publication Policy

Ethical Principles and Publication Policy

Price Policy